Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Robert Barrow

Recent news which mentions Robert Barrow

MindMed Calls FDA Experts To Validate LSD Drug Development Strategy
Tickers MNMD
Tags Psychedelic/Assisted Therapies Penny Stocks LSD program
From Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
Tickers MNMD
Tags Psychedelics Benzinga financial results
From Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
Tickers MNMD
Tags Generalized Anxiety Disorder News Small Cap
From Benzinga
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
Tickers MNMD OPNT
Tags Small Cap Psychedelics Market News
From Benzinga
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
Tickers GRUSF HALO MNMD XXII
Tags Michael Zercher MNMD General
From Benzinga
MindMed Appoints Schond L. Greenway As CFO
Tickers AVTX HALO MEOBF MNMD
Tags AVTX News Schond L/ Greenway
From Benzinga
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
Tickers MNMD
Tags Small Cap News Psychedelics
From Benzinga
MindMed Converts Shares To Have A Single Class
Tickers MNMD
Tags Benzinga Penny Stocks Robert Barrow
From Benzinga
Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event
Tickers CYBN FTRP MMDCF PSYC
Tags Penny Stocks Benzinga Kevin O’Leary
From Benzinga
MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years
Tickers MNMD
Tags News Regulations Topics
From Benzinga
Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth
Tickers AMZN CXXIF FLGC HCANF
Tags PSYC Robert Barrow appointments
From Benzinga
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
Tickers MNMD
Tags Ibogaine trial psychedelics MNMD
From Benzinga
Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams
Tickers CRDX CURLF MNMD TCNNF
Tags Ilera Healthcare MNMD General
From Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
Tickers MNMD
Tags MNMD News Small Cap
From Benzinga
MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
Tickers MNMD
Tags MNMD General psychedelics
From Benzinga
MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups
Tickers CRLBF MNMD
Tags Movers & Shakers Perry Dellelce News
From Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
Tickers MNMD NDAQ
Tags NDAQ Market News Robert Barrow
From Benzinga
Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty
Tickers AAWH MMNFF MNMD
Tags Imelda Walavalkar Matt Stang Robert Barrow
From Benzinga
Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed
Tickers BAC CGC CRARF CS
Tags Robert Barrow Markets News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.